Interaction Guide · Research summary

Can I take Paullinia Cupana with Tranylcypromine?

Review Paullinia Cupana with Tranylcypromine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Guarana can contribute substantial caffeine, so check with your prescriber before taking it with tranylcypromine. The concern is a potentially excessive stimulant load and a rise in blood pressure. The amount and other ingredients matter more than the word "natural" on the package.

What this answer covers

Oral Paullinia cupana seed preparations that contain caffeine. No assumption is made about the caffeine concentration of an unidentified brand, a different plant part or a caffeine-free preparation.

Supplement or preparation
Paullinia cupana
Medication ingredient
tranylcypromine

Guarana counts as caffeine

Some labels list guarana rather than listing a separate caffeine quantity. This does not make the product stimulant-free. Include it when describing coffee, tea, energy drinks and pre-workout products to your pharmacist.

What is known about this combination

Tranylcypromine carries a warning about excessive caffeine. That supports caution with caffeine-containing guarana, but it does not establish a clinical event rate for every guarana extract or dose.

Combination products add uncertainty

A product may also contain added caffeine or other stimulants. Information about one ingredient cannot clear the whole formulation for use. Bring the complete supplement label, including serving size, for review.

Avoid relying on a timing gap

There is no validated hours-apart schedule that makes a high caffeine exposure safe with this MAOI. Follow a prescriber-agreed plan and seek urgent care for a sudden severe headache, chest pain or severe blood-pressure symptoms.

Evidence and practical considerations

Side effects & toxicity

Guarana is a botanical caffeine source. Applying the tranylcypromine warning about excessive caffeine to caffeine-containing guarana is a constituent-based inference; no exact guarana-pair clinical trial was identified.

Exact scope
Oral Paullinia cupana seed preparations that contain caffeine. No assumption is made about the caffeine concentration of an unidentified brand, a different plant part or a caffeine-free preparation. with Oral tranylcypromine tablets; current sulfate-tablet labeling uses the named active ingredient.
Medication form and route
oral

What remains uncertain

  • Caffeine may be incompletely stated on labels. Direct guarana-MAOI outcome data and a safe dose threshold are lacking.

Factors that may matter: Exact supplement preparation and complete concomitant-medication list require assessment..

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: Current U.S. prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral tranylcypromine sulfate tablets.

The label contraindicates sympathomimetic supplements, hydroxytryptophan, tryptophan and SAM-e; it names St. John's wort in the serotonin-syndrome warning and lists excessive caffeine among exposures to avoid.

How this applies: Primary authority for exact tranylcypromine tablet precautions. Named supplements and class-based applications are kept distinct.

A labeled contraindication is not a measurement of the frequency of an event with each product; L-tyrosine and Panax ginseng are not individually named.

Source 2: Federal ingredient information

ods.od.nih.gov · Source check Sep 10, 2026

Population: Consumers of caffeine and botanical dietary supplements.

Guarana and tea can contribute caffeine, and a botanical ingredient list may omit the amount of caffeine. Caffeine has stimulant effects.

How this applies: General healthy-adult caffeine limits are not safety limits for patients receiving MAOIs. No exact guarana-MAOI trial is supplied.

General healthy-adult caffeine limits are not safety limits for patients receiving MAOIs. No exact guarana-MAOI trial is supplied.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Initial targeted research draft. Inspected source material, adjudicated the current checker statements, and recorded preparation limits. Clinical review has not occurred.
Research summary published

Article revision: 6604510f2ff57de1

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.